BIOMAT Database Logo BIOMAT Database Logo

Urinary albumin fragments as a new clinical parameter for the early detection of diabetic nephropathy. 1995

M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
Department of Internal Medicine, School of Medicine, Tokai University, Isehara.

Urinary albumin fragments (uAF) from patients with NIDDM were analyzed as a possible factor in the early discovery of diabetic nephropathy before emergence of microalbuminuria. SDS-PAGE and immunoblot assay were employed for detection of uAF. Samples from 252 patients with NIDDM, 158 patients with non-diabetic diseases, and 48 healthy volunteers were examined; uAF were detected in 139 (55.2%), 94 (59.5%), only one (2.1%), respectively. In diabetic patients with normoalbuminuria, uAF were detected in 48 out of 159 cases (30.2%). Two years after the initial study, 3 of the 17 diabetic patients (17.6%) with normoalbuminuria and uAF showed micro- or macroalbuminuria. It was concluded that detection of uAF might be useful for the early detection of diabetic nephropathy in NIDDM.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
[Radioimmunoassay of urinary albumin: early indicator of diabetic nephropathy?].
December 1985, La Revue de medecine interne,
M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion.
August 1982, Acta endocrinologica,
M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
[Diagnostic parameter in early diabetic nephropathy].
February 1991, Nihon rinsho. Japanese journal of clinical medicine,
M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
Urinary type IV collagen as a marker for early diabetic nephropathy.
March 1996, Diabetes research and clinical practice,
M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
Enhancing the predictive value of urinary albumin for diabetic nephropathy.
February 2006, Journal of the American Society of Nephrology : JASN,
M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
[Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
October 2020, Der Internist,
M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
Diabetic nephropathy: urinary albumin or total protein?
August 1989, Annals of internal medicine,
M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
January 2017, Nephrology (Carlton, Vic.),
M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
[Clinical significance of the detection of urinary albumin in diabetic patients].
March 1988, Zhonghua nei ke za zhi,
M Yagame, and D Suzuki, and K Jinde, and N Yano, and R Naka, and Y Abe, and Y Nomoto, and H Sakai, and H Suzuki, and Y Ohashi
[Early detection of diabetic nephropathy].
April 2008, Arquivos brasileiros de endocrinologia e metabologia,
Copied contents to your clipboard!